Efficacy of Ultrasound Guided Hyaluronic Injection in Treatment of Trigger Finger

Trigger Digit Clinical Trial

Official title:

Comparing the Efficacy of Ultrasound Guided Hyaluronic Injection With Ultrasound Guided Corticosteroid Injection in Treatment of Trigger Finger

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03131882
• Other study ID #: 05-58-04
• Status: Recruiting
• Phase: Phase 2/Phase 3
• First received: April 24, 2017
• Last updated: May 1, 2017
• Start date: October 1, 2016
• Est. completion date: September 30, 2017

Study information

• Verified date: May 2017
• Source: Mahidol University
• Contact: Picharn Pchyangkul, M.D.
• Phone: +6685-1197710
• Email: ppicharn[@]hotmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Comparing the Efficacy of Ultrasound Guided Hyaluronic Injection with Ultrasound Guided Corticosteroid Injection in Treatment of Trigger Finger

Description:

Randomized controlled trial which designed to compare the success rate, recurrence rate and functional outcomes of patients with trigger finger whom was treated with ultrasound guided hyaluronic acid injection to ultrasound guided corticosteroid injection

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 120
• Est. completion date: September 30, 2017
• Est. primary completion date: June 30, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years and older

Eligibility

Inclusion Criteria:

• Age > 20 years old

• Quinnell grade I, II, III

• Acute (< 6 months)

Exclusion Criteria:

• Quinnell grade IV

• Diabetes mellitus

• Rheumatoid arthritis

• Pregnancy

• Patient with prior injection or surgery of trigger finger

• Patient who are allergy to hyaluronic acid

Related Conditions & MeSH terms

• Trigger Digit
• Trigger Finger Disorder

Intervention

Drug:
• Hyaluronic Acid
1 ml of Low molecular weight hyaluronic acid injection under ultrasound guidance after subcutaneous 0.5ml of 1%lidocaine injection
• Triamcinolone Acetonide
1ml of 10 mg of triamcinolone injection under ultrasound guidance after subcutaneous 0.5 ml 1%lidocaine injection

Locations

Country	Name	City	State
Thailand	Faculty of medicine Ramathibodi hospital, Mahidol University	Ratchathewi	Bangkok

Sponsors (1)

Lead Sponsor	Collaborator
Mahidol University

Country where clinical trial is conducted

Thailand, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Success rate	reduction of symptom which needed no further treatment at follow up	1 month, 3 month, 6 months
Secondary	Pain score	Visual analogue scale changes	1 month, 3 month, 6 months
Secondary	Functional outcome	Disability of the arm, shoulder and hand score	1 month, 3 months, 6 months